SCHEMBL2183660

SCHEMBL2183660

Cc1cc(C2=CC[CH]C=C2)ccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 2/20 0.40
▸ UHRF1 Q96T88 1/20 0.38
▸ MAP4K4 O95819 3/20 0.35
▸ CCNC P24863 2/20 0.34
▸ CDK8 P49336 2/20 0.34
▸ PIK3CB P42338 1/20 0.33
▸ NFATC1 O95644 1/20 0.33
▸ CDC7 O00311 1/20 0.32
▸ ROCK2 O75116 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ CLK4 Q9HAZ1 1/20 0.32
▸ MKNK2 Q9HBH9 1/20 0.32
▸ IRAK4 Q9NWZ3 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ ABL1 P00519 1/20 0.32
▸ MAPK1 P28482 1/20 0.31
▸ PSEN1 P49768 1/20 0.31
▸ PSEN2 P49810 1/20 0.31
▸ APH1B Q8WW43 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1896511 0.71 DYRK1A (0.65) DYRK1AUHRF1MAP4K4CCNCCDK8
SCHEMBL30308690 0.71 DYRK1A (0.65) DYRK1AUHRF1MAP4K4CCNCCDK8
Iodide SCHEMBL9618570 0.69 DYRK1A (0.63) DYRK1AUHRF1MAP4K4CCNCCDK8
SCHEMBL18406785 0.65 DYRK1A (0.53) DYRK1AUHRF1MAP4K4CCNCCDK8
SCHEMBL8964255 0.64 DYRK1A (0.62) DYRK1AUHRF1MAP4K4CCNCCDK8
SCHEMBL31119862 0.64 DYRK1A (0.62) DYRK1AUHRF1MAP4K4CCNCCDK8
SCHEMBL27971540 0.63 WNT3A (0.52) DYRK1AUHRF1MAP4K4CCNCCDK8
SCHEMBL30559511 0.62 DYRK1A (0.60) DYRK1AUHRF1MAP4K4CDC7ROCK2
SCHEMBL134658 0.62 DYRK1A (0.60) DYRK1AUHRF1MAP4K4CDC7ROCK2
Hydrochloric Acid SCHEMBL30657718 0.62 DYRK1A (0.60) DYRK1AUHRF1MAP4K4CCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166132-A1 Gamma Secretase Modulators AMGEN INC. (US) 2011-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166132-A1 Gamma Secretase Modulators BACE1, BACE2, PSEN1 DYRK1A 4479/4885UHRF1 4060/4885MAP4K4 3826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback